• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by PPD, Inc.

    12/9/21 5:06:56 PM ET
    $PPD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Get the next $PPD alert in real time by email
    SC 13G 1 d251725dsc13g.htm SC 13G SC 13G

     

     

    Securities and Exchange Commission

    Washington, D.C. 20549

     

     

    Schedule 13G

    (Rule 13d-102)

    Information to be Included in Statements Filed Pursuant

    to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed

    Pursuant to § 240.13d-2

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (Amendment No.    )*

     

     

    PPD, Inc.

    (Name of Issuer)

    Common Stock, par value $0.01 per share

    (Title of Class of Securities)

    69355F102

    (CUSIP Number)

    December 8, 2021

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 69355F102    Schedule 13G    Page 1 of 15

     

      1    

      Names of Reporting Persons

     

      The Carlyle Group Inc.

      2  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5     

      Sole Voting Power

     

      0

       6   

      Shared Voting Power

     

      0

       7   

      Sole Dispositive Power

     

      0

       8   

      Shared Dispositive Power

     

      0

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      0%

    12  

      Type of Reporting Person

     

      CO


    CUSIP No. 69355F102    Schedule 13G    Page 2 of 15

     

      1    

      Names of Reporting Persons

     

      Carlyle Group Management L.L.C.

      2  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5     

      Sole Voting Power

     

      0

       6   

      Shared Voting Power

     

      0

       7   

      Sole Dispositive Power

     

      0

       8   

      Shared Dispositive Power

     

      0

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      0%

    12  

      Type of Reporting Person

     

      OO (Limited Liability Company)


    CUSIP No. 69355F102    Schedule 13G    Page 3 of 15

     

      1    

      Names of Reporting Persons

     

      Carlyle Holdings II GP L.L.C.

      2  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5     

      Sole Voting Power

     

      0

       6   

      Shared Voting Power

     

      0

       7   

      Sole Dispositive Power

     

      0

       8   

      Shared Dispositive Power

     

      0

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      0%

    12  

      Type of Reporting Person

     

      OO (Limited Liability Company)


    CUSIP No. 69355F102    Schedule 13G    Page 4 of 15

     

      1    

      Names of Reporting Persons

     

      Carlyle Holdings II L.L.C.

      2  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5     

      Sole Voting Power

     

      0

       6   

      Shared Voting Power

     

      0

       7   

      Sole Dispositive Power

     

      0

       8   

      Shared Dispositive Power

     

      0

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      0%

    12  

      Type of Reporting Person

     

      OO (Limited Liability Company)


    CUSIP No. 69355F102    Schedule 13G    Page 5 of 15

     

      1    

      Names of Reporting Persons

     

      CG Subsidiary Holdings L.L.C.

      2  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5     

      Sole Voting Power

     

      0

       6   

      Shared Voting Power

     

      0

       7   

      Sole Dispositive Power

     

      0

       8   

      Shared Dispositive Power

     

      0

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      0%

    12  

      Type of Reporting Person

     

      OO (Limited Liability Company)


    CUSIP No. 69355F102    Schedule 13G    Page 6 of 15

     

      1    

      Names of Reporting Persons

     

      TC Group Cayman Investment Holdings, L.P.

      2  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      Cayman Islands

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5     

      Sole Voting Power

     

      0

       6   

      Shared Voting Power

     

      0

       7   

      Sole Dispositive Power

     

      0

       8   

      Shared Dispositive Power

     

      0

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      0%

    12  

      Type of Reporting Person

     

      PN


    CUSIP No. 69355F102    Schedule 13G    Page 7 of 15

     

      1    

      Names of Reporting Persons

     

      TC Group Cayman Investment Holdings Sub L.P.

      2  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      Cayman Islands

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5     

      Sole Voting Power

     

      0

       6   

      Shared Voting Power

     

      0

       7   

      Sole Dispositive Power

     

      0

       8   

      Shared Dispositive Power

     

      0

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      0%

    12  

      Type of Reporting Person

     

      PN


    CUSIP No. 69355F102    Schedule 13G    Page 8 of 15

     

      1    

      Names of Reporting Persons

     

      TC Group VI, L.L.C.

      2  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5     

      Sole Voting Power

     

      0

       6   

      Shared Voting Power

     

      0

       7   

      Sole Dispositive Power

     

      0

       8   

      Shared Dispositive Power

     

      0

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      0%

    12  

      Type of Reporting Person

     

      OO (Limited Liability Company)


    CUSIP No. 69355F102    Schedule 13G    Page 9 of 15

     

      1    

      Names of Reporting Persons

     

      TC Group VI, L.P.

      2  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5     

      Sole Voting Power

     

      0

       6   

      Shared Voting Power

     

      0

       7   

      Sole Dispositive Power

     

      0

       8   

      Shared Dispositive Power

     

      0

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      0%

    12  

      Type of Reporting Person

     

      PN


    CUSIP No. 69355F102    Schedule 13G    Page 10 of 15

     

      1    

      Names of Reporting Persons

     

      Carlyle Partners VI Holdings II, L.P.

      2  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5     

      Sole Voting Power

     

      0

       6   

      Shared Voting Power

     

      0

       7   

      Sole Dispositive Power

     

      0

       8   

      Shared Dispositive Power

     

      0

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      0%

    12  

      Type of Reporting Person

     

      PN


    CUSIP No. 69355F102    Schedule 13G    Page 11 of 15

     

    ITEM 1. (a)

    Name of Issuer:

    PPD, Inc. (the “Issuer”)

     (b) Address of Issuer’s Principal Executive Offices:

    929 North Front Street

    Wilmington, NC 28401

     

    ITEM 2. (a)

    Name of Person Filing:

    Each of the following is hereinafter individually referred to as a “Reporting Person” and collectively as the “Reporting Persons.” This statement is filed on behalf of:

    Carlyle Group Management L.L.C.

    The Carlyle Group Inc.

    Carlyle Holdings II GP L.L.C.

    Carlyle Holdings II L.L.C.

    CG Subsidiary Holdings L.L.C.

    TC Group Cayman Investment Holdings, L.P.

    TC Group Cayman Investment Holdings Sub L.P.

    TC Group VI, L.L.C.

    TC Group VI, L.P.

    Carlyle Partners VI Holdings II, L.P.

     (b) Address or Principal Business Office:

    The address for each of TC Group Cayman Investment Holdings, L.P. and TC Group Cayman Investment Holdings Sub L.P. is c/o Walkers, 190 Elgin Avenue, George Town, Grand Cayman KY1-9001, Cayman Islands. The address for each of the remaining Reporting Persons is c/o The Carlyle Group Inc., 1001 Pennsylvania Avenue NW, Suite 220 South, Washington, D.C. 20004-2505.

     (c) Citizenship of each Reporting Person is:

    Each of TC Group Cayman Investment Holdings, L.P. and TC Group Cayman Investment Holdings Sub L.P. is organized under the laws of the Cayman Islands. Each of the remaining Reporting Persons is organized under the laws of the state of Delaware.

     (d) Title of Class of Securities:

    Common stock, par value $0.01 per share (“Common Stock”).


    CUSIP No. 69355F102    Schedule 13G    Page 12 of 15

     

    (e) CUSIP Number:

    69355F102

     

    ITEM 3.

    Not applicable.

     

    ITEM 4.

    Ownership.

    (a-c)

    This amendment to Schedule 13G is being filed on behalf of the Reporting Persons to report that, as of December 8, 2021, the Reporting Persons do not beneficially own any shares of Common Stock.

     

    ITEM 5.

    Ownership of Five Percent or Less of a Class.

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ☒

     

    ITEM 6.

    Ownership of More than Five Percent on Behalf of Another Person.

    Not applicable.

     

    ITEM 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

    Not applicable.

     

    ITEM 8.

    Identification and Classification of Members of the Group.

    Not applicable.

     

    ITEM 9.

    Notice of Dissolution of Group.

    Not applicable.

     

    ITEM 10.

    Certification.

    Not applicable.


    CUSIP No. 69355F102    Schedule 13G    Page 13 of 15

     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: December 9, 2021

     

    Carlyle Group Management L.L.C.
    By:  

    /s/ Anne Frederick, attorney-in-fact

    Name:   Curtis L. Buser
    Title:   Chief Financial Officer
    The Carlyle Group Inc.
    By:  

    /s/ Anne Frederick, attorney-in-fact

    Name:   Curtis L. Buser
    Title:   Managing Director and Chief Financial Officer
    Carlyle Holdings II GP L.L.C.
    By: The Carlyle Group Inc., its sole member
    By:  

    /s/ Anne Frederick, attorney-in-fact

    Name:   Curtis L. Buser
    Title:   Managing Director and Chief Financial Officer
    Carlyle Holdings II L.L.C.
    By:  

    /s/ Anne Frederick, attorney-in-fact

    Name:   Curtis L. Buser
    Title:   Managing Director
    CG Subsidiary Holdings L.L.C.
    By:  

    /s/ Anne Frederick, attorney-in-fact

    Name:   Curtis L. Buser
    Title:   Managing Director


    CUSIP No. 69355F102    Schedule 13G    Page 14 of 15

     

    TC Group Cayman Investment Holdings, L.P.
    By: CG Subsidiary Holdings L.L.C., its general partner
    By:  

    /s/ Anne Frederick, attorney-in-fact

    Name:   Curtis L. Buser
    Title:   Managing Director
    TC Group Cayman Investment Holdings Sub L.P.
    By: TC Group Cayman Investment Holdings, L.P., its general partner
    By: CG Subsidiary Holdings L.L.C., its general partner
    By:  

    /s/ Anne Frederick, attorney-in-fact

    Name:   Curtis L. Buser
    Title:   Managing Director
    TC Group VI, L.L.C.
    By:  

    /s/ Jeremy W. Anderson

    Name:   Jeremy W. Anderson
    Title:   Authorized Person
    TC Group VI, L.P.
    By:  

    /s/ Jeremy W. Anderson

    Name:   Jeremy W. Anderson
    Title:   Authorized Person
    Carlyle Partners VI Holdings II, L.P.
    By: TC Group VI, L.P., its general partner
    By:  

    /s/ Jeremy W. Anderson

    Name:   Jeremy W. Anderson
    Title:   Authorized Person


    CUSIP No. 69355F102    Schedule 13G    Page 15 of 15

     

    LIST OF EXHIBITS

     

    Exhibit No.

      

    Description

    24    Power of Attorney (incorporated by reference to Exhibit 24 to the Schedule 13G filed by the Reporting Persons on February 12, 2021).
    99    Joint Filing Agreement (incorporated by reference to Exhibit 99 to the Schedule 13G filed by the Reporting Persons on February 12, 2021).
    Get the next $PPD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PPD

    DatePrice TargetRatingAnalyst
    8/5/2021$47.50Neutral
    Credit Suisse
    More analyst ratings

    $PPD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Saama Appoints Scott Rogers as Company's Chief Financial Officer

      Scott brings a unique combination of financial and clinical fused with growth experience to Saama New CFO appointment follows October announcement of $430M growth investment Saama Technologies, Inc. ("Saama") today announced that Scott Rogers, 17-year industry veteran, has been appointed as the company's Chief Financial Officer, effective January 31, 2022. In this position Scott is responsible for leading the company's global finance organization and will report to Saama Founder and CEO Suresh Katta. Scott comes to Saama with significant financial executive experience in clinical development, commercial growth, and financial reporting and compliance. He progressed rapidly through the

      2/2/22 8:00:00 AM ET
      $PPD
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Thermo Fisher Scientific Completes Acquisition of PPD, Inc.

      WALTHAM, Mass., Dec. 8, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it has completed its acquisition of PPD, Inc. (NASDAQ:PPD), a leading global provider of clinical research services to the biopharma and biotech industry, for $17.4 billion. "We are very excited to officially welcome our PPD colleagues to Thermo Fisher Scientific," said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher Scientific. "Expanding our value proposition for our biotech and pharmaceutical customers with the addition of PPD's leading clinical research services advances our work in bringing life-changing therapi

      12/8/21 8:45:00 AM ET
      $PPD
      $TMO
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
      Industrial Machinery/Components
      Industrials
    • PPD Named to 'Best Workplaces in Greater China' for Second Consecutive Year

      PPD, Inc. (NASDAQ:PPD) was named one of the "Best Workplaces in Greater China™ 2021" by Great Place to Work® for successfully creating an inclusive workplace experience for employees. PPD has more than 20 years of experience in the Asia-Pacific region, including providing a broad range of clinical development and laboratory services in Greater China. This is the second year PPD has received this recognition from Great Place to Work®, a global authority on high-trust, high-performance workplace cultures. "We remain committed to providing a healthy and open work environment for our employees, and this award shows that we continue to be successful in our efforts for yet another year," said D

      12/7/21 9:00:00 AM ET
      $PPD
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $PPD
    Leadership Updates

    Live Leadership Updates

    See more
    • Saama Appoints Scott Rogers as Company's Chief Financial Officer

      Scott brings a unique combination of financial and clinical fused with growth experience to Saama New CFO appointment follows October announcement of $430M growth investment Saama Technologies, Inc. ("Saama") today announced that Scott Rogers, 17-year industry veteran, has been appointed as the company's Chief Financial Officer, effective January 31, 2022. In this position Scott is responsible for leading the company's global finance organization and will report to Saama Founder and CEO Suresh Katta. Scott comes to Saama with significant financial executive experience in clinical development, commercial growth, and financial reporting and compliance. He progressed rapidly through the

      2/2/22 8:00:00 AM ET
      $PPD
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care